Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X Trials. [PDF]
Reveille JD +11 more
europepmc +1 more source
Mental health in patients with rheumatoid arthritis and axial spondyloarthritis: a cross-sectional, case-control tertiary centre study from Czechia. [PDF]
Husakova M +7 more
europepmc +1 more source
Difficult to manage axial spondyloarthritis patients have high burden of pain-related comorbidities and adverse long-term outcome. [PDF]
Bertsias A +8 more
europepmc +1 more source
Factors affecting employment in Japanese patients with ankylosing spondylitis (AS). [PDF]
Furusawa H +6 more
europepmc +1 more source
Utility of Magnetic Resonance Imaging in Assessing Disease Activity in Axial Spondyloarthritis Regardless of C-Reactive Protein Status. [PDF]
Chen J +4 more
europepmc +1 more source
Association between SARC-F as a self-report screening tool for sarcopenia and muscle strength, physical performance, daily activity, patient-reported outcomes and body composition in patients with spondyloarthritis. [PDF]
Kononenko J +6 more
europepmc +1 more source
Use of nonsteroidal anti-inflammatory drugs in patients with axial spondyloarthritis receiving biotherapy and associated factors: a prospective cohort study. [PDF]
Charoui C +6 more
europepmc +1 more source
Xeligekimab, an Interleukin-17A Antagonist for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 48-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study. [PDF]
Zhang S +41 more
europepmc +1 more source

